Health-Related Quality of Life and Coping Strategies in a Cohort Study of Highly Active Antiretroviral Therapy Naïve Patients Adherence
Table 2
QoL dimensions measured at the start of treatment after 12 and 24 months of follow-up.
Quality of life dimensions (QoLD)
QoLD scores (T0)
QoLD scores (T1)
value
QoLD scores (T2)
value
M
SD
Md
p25
p75
M
SD
Md
p25
p75
M
SD
Md
p25
p75
Physical (D1)
15.4
3.5
16.0
14.0
18.0
16.4
3.1
17.0
15.0
19.0
≤0.001
16.7
2.7
18.0
15.0
19.0
≤0.001
Psychological (D2)
14.6
3.1
14.4
12.8
16.8
15.4
2.9
16.0
13.6
17.6
≤0.001
15.7
2.7
16.0
14.4
17.6
≤0.001
Level of independence (D3)
15.3
3.3
16.0
14.0
17.0
16.1
2.7
17.0
15.0
18.0
0.006
16.1
2.9
17.0
15.0
18.0
0.012
Social relationships (D4)
14.6
3.5
15.0
12.0
17.0
14.7
3.8
15.0
13.0
17.0
0.447
14.9
3.3
16.0
13.0
17.0
0.466
Environment (D5)
14.1
2.9
14.5
12.5
16.0
14.9
2.5
15.0
13.0
17.0
0.002
15.0
2.3
15.5
14.0
16.5
0.001
Spirituality/religion/personal beliefs (D6)
13.9
4.1
14.0
11.0
17.0
15.1
3.5
15.0
13.0
18.0
≤0.001
15.3
3.1
16.0
14.0
18.0
0.001
Total quality of life (TQoL)
14.6
2.5
14.8
13.3
16.3
15.4
2.3
15.7
13.8
17.3
≤0.001
15.6
2.1
15.9
14.5
17.2
≤0.001
M: mean; SD: standard deviation; Md: median; p25: percentile 25; p75: percentile 75; T0: beginning of the ART treatment; T1: 12 months follow-up; T2: 24 months follow-up;Wilcoxon test, QoL scores T0, and QoL scores T1; Wilcoxon test, QoL scores T0, and QoL scores T2.
